Patent Assignment
Reel/Frame 036770/0029
Assignment of Assignor's Interest
Recorded: 2015-10-12
Pages: 7
Assignor
NOVARTIS PHARMA AG
Executed: 2015-03-02
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Property
(1)
Pharmaceutical Combination of a VEGFR Inhibitor and a MEK Inhibitor for Treating Cancer
Application:
13/819,091 →
Publication:
US 2013/0165456
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 25, 2014
From: GLAXOSMITHKLINE LLC
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 033598/0552 →
Assignment of Assignor's Interest
Aug 25, 2014
From: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
Reel/Frame 033598/0574 →
Assignment of Assignor's Interest
Oct 12, 2015
From: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED
To: NOVARTIS PHARMA AG
Reel/Frame 036770/0010 →